3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Renal Insufficiency, Chronic
1
Renal Insufficiency
1
Lymphoma, Follicular
1
Heart Failure
1
Interventions
Rituximab
52
Cyclophosphamide
49
Lenalidomide
40
fludarabine
24
obinutuzumab
22
Prednisone
18
Magnetic Resonance Spectroscopy
18
Bendamustine Hydrochloride
18
Vincristine
16
fludarabine phosphate
15
Specimen Handling
15
Doxorubicin
15
zanubrutinib
13
Biopsy
12
tazemetostat
10
ibrutinib
10
Whole-Body Irradiation
10
pembrolizumab
9
Peripheral Blood Stem Cell Transplantation
9
venetoclax
8
Mycophenolic Acid
7
Etoposide
7
axicabtagene ciloleucel
6
Radiotherapy
6
CT-P10
6
Therapeutics
5
R-CHOP protocol
5
tisagenlecleucel
4
tafasitamab
4
polatuzumab vedotin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
Eplerenone
×
1 year
×
Clear all
NCT07029503
2026-02-24
SCARF-1
Karolinska Institutet
Phase 2
Recruiting
40 enrolled